Immucor Italia S.P.A.
Part of Immucor Inc.
Company facts
- FY2025 rankings
-
Its parent company, Immucor Inc., ranks:
- Self-certified in SAM.gov
- Entity structure
- Other
- Corporate family
-
-
Parent
Norcross, GA
KV8AGJX7NMZ7
-
Parent
Norcross, GA
KV8AGJX7NMZ7
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $31,473 |
| FY2023 | $7,640 |
Contract awards
Similar vendors
About the company
Immucor Italia S.P.A. is a for-profit organization registered to receive federal contract awards from the U.S. government. The company specializes in providing medical screening equipment, particularly PANOSCREEN I, II, and III products, to support global health protection programs. Immucor Italia S.P.A. has been actively engaged in federal contracting since at least June 2023, with its current registration in the System for Award Management (SAM.gov) valid until May 27, 2025.
The Defense Health Agency (DHA) has been the primary federal agency awarding contracts to Immucor Italia S.P.A. The company has received multiple firm fixed-price delivery orders for its PANOSCREEN I, II, and III products. These orders have ranged in value from approximately $7,000 to $13,000, with completion dates spanning from October 2023 to December 2024. All of these awards have been made on the open market without any set-aside designations, indicating that Immucor Italia S.P.A. competes for these contracts in a full and open competition environment. The consistent nature of these awards suggests that the company's medical screening equipment plays a crucial role in supporting the DHA's global health protection initiatives.
Immucor Italia S.P.A. holds a significant Indefinite Delivery Contract (IDC) with the Defense Health Agency, awarded on June 13, 2023. This single-award IDC has a ceiling value of $138,594.60 and an ultimate completion date of June 12, 2028. The contract vehicle is specifically for the provision of PANOSCREEN I, II, and III products, aligning with the company's expertise in medical screening equipment. This IDC serves as the parent vehicle for the subsequent delivery orders awarded to Immucor Italia S.P.A., allowing the DHA to efficiently procure these essential medical supplies over an extended period. The substantial ceiling value and five-year duration of this IDC underscore the government's long-term commitment to utilizing Immucor Italia S.P.A.'s products in its healthcare operations.
Quick answers
Is Immucor Italia S.P.A. registered in SAM.gov?
Immucor Italia S.P.A.'s SAM.gov registration expired on May 27, 2025.
What is Immucor Italia S.P.A.'s CAGE code?
Immucor Italia S.P.A.'s CAGE code is A0989, and its Unique Entity ID (UEI) is VXJRVAYZFTK3.
How much has Immucor Italia S.P.A. received in federal contracts?
Federal contracts obligated $39,113 to Immucor Italia S.P.A. in fiscal years 2023 through 2027.
How does Immucor Italia S.P.A. rank among federal contractors?
Immucor Italia S.P.A.'s parent company, Immucor Inc., ranked #11 in NAICS 325413, #22 in PSC 6550 and #23 in PSC W066 in FY2025.
What is Immucor Italia S.P.A.'s most recent federal award?
Immucor Italia S.P.A.'s most recent federal contract award is 0002381 panoscreen I, II and III incl (N6817124F2066), from Naval Supply Systems Command (Navy), on May 29, 2024.
On GovTribe
See Immucor Italia S.P.A.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors